Universität Witten/Herdecke

University / College


Location: Witten/Herdecke, Germany (DE) DE

ISNI: 0000000090246397

ROR: https://ror.org/00yq55g44

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Corrigendum: Position statement and updated international guideline for safe and effective whole-body electromyostimulation training-the need for common sense in WB-EMS application (Frontiers in Physiology, (2023), 14, (1174103), 10.3389/fphys.2023.1174103) (2023) Kemmler W, Fröhlich M, Ludwig O, Eifler C, von Stengel S, Willert S, Teschler M, et al. Journal article, Erratum Rapid recovery of poststroke cardiac autonomic dysfunction: Causes to be considered (2023) Wang R, Moeller S, Akhundova A, Marthol H, Kollmar R, Köhrmann M, Hilz MJ Journal article Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API) (2023) Speckmann C, Nennstiel U, Hoenig M, Albert MH, Ghosh S, Schuetz C, Brockow I, et al. Journal article Epidemiology and Characteristics of Gastric Carcinoma in Childhood—An Analysis of Data from Population-Based and Clinical Cancer Registries (2023) Abele M, Grabner L, Blessing T, Block A, Agaimy A, Kratz C, Simon T, et al. Journal article Prioritization preferences for COVID-19 vaccination are consistent across five countries (2022) Munzert S, Ramirez-Ruiz S, Çalı B, Stoetzer LF, Gohdes A, Lowe W Journal article Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry (2022) Blank N, Schmalzing M, Moinzadeh P, Oberste M, Siegert E, Mueller-Ladner U, Riemekasten G, et al. Journal article S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid (2022) Hofmann SC, Gunther C, Bockle BC, Didona D, Ehrchen J, Gaskins M, Geerling G, et al. Journal article GeparPiPPa- A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC) (2022) Loibl S, Reinisch M, Denkert C, Schneeweiss A, Seiler S, Fasching P, Hanusch C, et al. Conference contribution Thrombospondin-2 and LDH: potential predictive biomarkers for the treatment of metastatic renal cell carcinoma with everolimus after one VEGF-targeted therapy (MARC-2 study) (2022) Zeuschner P, Hoelters S, Stoeckle M, Seliger B, Mueller A, Bachmann HS, Gruenwald V, et al. Conference contribution Prevalence of sport injuries in Olympic combat sports: a cross-sectional study examining one Olympic period (2022) Lambert C, Ritzmann R, Lambert S, Lachmann D, Malliaropoulos NG, Gesslein M, Peters N, Shafizadeh S Journal article